Search
Showing results for "clinical trials"
Meet Kelly – the latest addition to the PMH Diabetes and Endocrinology clinic.
Inklings Practitioner
Senior Speech Pathologist
CliniKids has partnered with Autism CRC to deliver an online self-paced short course which explores the Recommendations included within the National Guideline for supporting the learning, participation, and wellbeing of autistic children and their families in Australia.
We are currently working through several clinical audits to ensure that we are meeting our service delivery standards and governance requirements. As part of this, we have audited our Service Agreements to ensure that we have a signed agreement on file for all our clients. This agreement is an NDIS
We tested the hypothesis that treatment of CF epithelial cells with ivacaftor (Iva) or ivacaftor/lumacaftor (Iva/Lum) would improve control of rhinovirus infection.
Alexithymia is characterised by difficulties identifying and describing feelings, as well as a lack of focus on feelings. Alexithymia is a transdiagnostic risk factor for developing a wide array of psychopathologies, such as anxiety and depression, with a key hypothesised mechanism being the impairing impact of alexithymia on emotion regulation competency. However, no study has tested whether difficulties with emotion regulation mediate the link between alexithymia and psychopathological symptoms using longitudinal designs.
Estimate the global prevalence of neurodevelopmental impairment in children with Robin sequence (RS) at one year or more of age.
Mild stroke affects more than half the stroke population, yet there is limited evidence characterizing cognition over time in this population, especially with predictive approaches applicable at the individual-level. We aimed to identify patterns of recovery and the best combination of demographic, clinical, and lifestyle factors predicting individual-level cognitive state at 3- and 12-months after mild stroke.
Glycemia risk index (GRI) is a novel composite metric assessing overall glycemic risk, accounting for both hypoglycemia and hyperglycemia and weighted toward extremes. Data assessing GRI as an outcome measure in closed-loop studies and its relation with conventional key continuous glucose monitoring (CGM) metrics are limited.